Oxyresveratrol, a compound in the heartwood of Artocarpus lakoocha Roxb and other medicinal plants, has been shown to have various biological activities. However, these have not been studied in periodontal research. In this study, we investigated whether oxyresveratrol has antibacterial activity against the predominant perio-pathogenic bacteria Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. Moreover, the anti-inflammatory properties of oxyresveratrol were studied in LPS-stimulated human periodontal ligament (hPDL) cells. The antibacterial activity of oxyresveratrol on P. gingivalis and A. actinomycetemcomitans was initially evaluated using a disc diffusion test. The anti-bacterial strength of oxyresveratrol was then assessed in vitro by determining the minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC). Furthermore, the effects of oxyresveratrol on the LPS-induced production of inflammatory mediators were measured in hPDL cells. The levels of cytokine mRNA and protein expression were determined using reverse transcriptase-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Our results showed that oxyresveratrol exhibited antibacterial activities against P. gingivalis with MIC and MBC values of 0.07 mg/mL and 0.16 mg/mL, respectively. The MIC and MBC values against A. actinomycetemcomitans were 0.08 mg/mL and 0.16 mg/mL, respectively. When examining inflammatory stimulation, LPS treatment strongly induced the expression of pro-inflammatory cytokines in hPDL cells. However, pre-treatment with oxyresveratrol significantly inhibited the expression of IL-6 and IL-8 at both the mRNA and protein levels. The IL-1β mRNA level was suppressed by oxyresveratrol, but the level of secreted IL-1β protein was not detectable using ELISA. The results of the present study indicate that oxyresveratrol is a potential candidate for use as an anti-periodontitis agent because of its anti-bacterial activity against the main oral pathogens related to periodontal disease and its anti-inflammatory activity in LPS-stimulated hPDL cells.
Periodontal disease is one of the most crucial global oral health problems [1] . More than two-thirds of the world's population suffers from some form of periodontitis [2] . Periodontitis is an inflammatory disease caused by groups of anaerobic Gram-negative bacteria, such as Porphyromonas gingivalis [3] and Actinobacillus actinomycetemcomitans [4] . The disease is clinically differentiated from gingivitis by the loss of the connective tissue attachment to the teeth [5] .
Presently, the treatment for periodontitis that is generally used by dentists is scaling and root planning, which remove bacteria and bacterial deposits from the gingival and tooth surfaces [6] . In addition, a 0.12% chlorhexidine mouthwash is also used as an adjunct treatment [7] . Although this is considered to be the most effective antiseptic mouthwash [8] , there are several disadvantages to its use, including causing brown stains on the teeth and tongue and altering taste perception; these treatments might cause side effects in some patients [9] [10] [11] . The search for alternative agents based on herbal extracts or natural compounds is thus necessary.
The natural compound focused on in this study is oxyresveratrol (2,3′,4,5′-tetrahydroxystilbene) from the Thai medicinal plant Artocarpus lakoocha [12] . Oxyresveratrol has been found in various plants, including the heartwood and fruits of A. heterophyllus, A. lakoocha, A. gomezianus, A. dadah, the wood extracts and fruits of mulberry trees (Morus australis, M. alba), the fruits of Melaleuca leucadendron, the rhizome of Smilacis chinae, and the Egyptian herb Schoenocaulon officinale [13] [14] [15] [16] [17] [18] [19] . Water-soluble oxyresveratrol is known for its antiviral and hepato-protective properties. Importantly, oxyresveratrol has also been shown to have, protection against DNA damage [20] , anti-inflammatory and antibacterial activities [21] . Thus, this compound has the potential to be an effective agent in the treatment of periodontal disease.
In this study, the anti-periodontal bacterial activity of oxyresveratrol was investigated against oral pathogens. Moreover, its inflammatory activity was tested in LPS-stimulated human periodontal ligament fibroblast cells (hPDL). Our findings suggested that oxyresveratrol could be developed as an antiperiodontitis agent for future clinical use.
The antibacterial activity of oxyresveratrol was tested against two major bacterial causes of periodontal disease, P. gingivalis and A. actinomycetemcomitans, and two of dental caries, Streptococcus mutans, and Streptococcus sobrinus. Clear inhibition zones were found 48 h and 72 h after incubation at 37°C for NPC Natural Product Communications The excess accumulation of periodontal bacteria causes inflammation in the local periodontal tissue [22] . Bacterial lipopolysaccharide (LPS) is a major cell wall component of Gramnegative bacteria, and possesses marked immunological and pharmacological activities, such as stimulation of bone resorption [23, 24] . Moreover, the LPS from periodontal bacteria is able to induce pro-inflammatory cytokines [25] [26] [27] . Previous studies have also demonstrated increases in IL-1, IL-6, IL-8, and tumor necrosis factor levels in diseased periodontal sites compared with healthy or inactive sites [28] [29] [30] [31] . Because periodontal disease is related to the inflammatory response, an anti-inflammatory effect is one of the potential targets for periodontitis treatment.
Before studying the anti-inflammatory activity of oxyresveratrol, its effect on human periodontal ligament (hPDL) cell viability was investigated. The hPDL cells were incubated with different concentrations of oxyresveratrol for 24 hours. The cell viability was measured using an MTT assay. The result showed that the cells died when they were treated with oxyresveratrol concentrations of 25 µg/mL or higher for 24 hours ( Figure 1 ). Thus, the concentration of oxyresveratrol used in subsequent experiments was 20 µg/mL, which showed no effect on hPDL cell viability.
To study the anti-inflammatory activity of oxyresveratrol, lipopolysaccharide (LPS) from P. gingivalis was used to mimic inflammatory conditions in hPDL cells. As shown in Fig. 2 , LPS treatment markedly increased the expression of IL-1, IL-6, and IL-8 mRNA. Interestingly, oxyresveratrol clearly suppressed the mRNA expression of these pro-inflammatory cytokines in a dosedependent manner. Using ELISA, the levels of IL-6 and IL-8 protein were found to correspond to their respective mRNA levels ( Figure 3 ). This confirmed that oxyresveratrol could suppress the pro-inflammatory cytokines IL-6 and IL-8 at the transcriptional level. For IL-1, the secreted IL-1 protein was not detectable by ELISA (data not shown). Our result showed that oxyresveratrol decreased IL-1 at the mRNA level (Figure 2 ), but not at the protein level ( Figure 3 ). Our result resembles that of a previous study [32] , which showed that the secretions of IL-1 from LPSinduced human macrophage, human bone marrow, and human gingival fibroblast cells were very low or undetectable, although they could detect the IL-1 mRNA. These findings indicated that oxyresveratrol could inhibit the expression of the pro-inflammatory cytokines IL-6 and IL-8 at both the mRNA and protein levels. The effective concentration of oxyresveratrol for anti-inflammatory activity is 20 µg/mL. This concentration did not affect hPDL viability at 24 hours ( Figure 1 ). However, the MICs for P. gingivalis and A. actinomycetemcomitans were 80 µg/mL and 40 µg/mL, respectively. These concentrations significantly decreased the viability of the hPDL cells at 24 hours. Thus, studies of the antiinflammatory activity of oxyresveratrol on other oral cells and timekill studies on the periodontal pathogens are necessary to evaluate the optimal concentration for further use.
In conclusion, our results suggest that oxyresveratrol has potential to be developed as a periodontitis treatment because of its antiperiodontal pathogen and anti-inflammatory activities. Therefore, further research into oxyresveratrol as an anti-periodontitis treatment has promise. 
Experimental
Antimicrobial activity: The antibacterial activity of oxyresveratrol was evaluated using a disc diffusion method on an agar medium. P. gingivalis and A. actinomycetemcomitans were grown on anaerobic Brucella blood-agar and blood-agar plates, respectively in an anaerobic environment at 37°C for 3-5 days. S. mutans and S. sobrinus were grown in brain -heart infusion agar at 5% CO 2 at 37°C for 24 h. Oxyresveratrol [12] at 10 mg/mL was introduced onto the disc and allowed to dry. Then, the disc was impregnated onto the seeded agar plate. Dimethyl sulfoxide (DMSO) was used as a negative control, whereas 0.12% chlorhexidine was used as a positive control. The plating was performed in triplicate, and the plates were incubated for 48 h at 37°C to assess the antibacterial activity. The antimicrobial activity was determined based on the diameter of the zone of inhibition, and the mean of 3 readings is presented.
Determination of MIC and MBC values:
The minimal inhibitory concentration (MIC) value of oxyresveratrol was determined for P. gingivalis and A. actinomycetemcomitans. This measurement was modified from a previous study [33] . Briefly, 100 µL of 10 µg/mL oxyresveratrol was added to the plate, and dilutions were made. Subsequently, 100 µL of dilute A. actinomycetemcomitans suspension with a final inoculum of 10 5 bacteria/mL was added to the microtiter plate. For P. gingivalis, 1 mL of dilute bacterial suspension was added to the tubes with different dilutions of oxyresveratrol. The experiment was performed in triplicate. A bacterial suspension with 10% DMSO was used as a negative control, and 0.12% chlorhexidine was used as a positive control. Following incubation under anaerobic conditions, the MIC was determined by the lowest concentration of oxyresveratrol with bacterial growth. The minimum bactericidal concentration (MBC) value was determined by a subculture of the wells that showed no bacterial growth on sterile agar plates. The MBC was determined by the lowest concentration that showed no visible growth on the agar plate.
Preparation and culture of hPDL cells: Human PDL cells were obtained from healthy teeth extracted for orthodontic reasons with informed consent, as previously described [34] . The protocol was approved by the Ethical Committee of the Faculty of Dentistry at Chulalongkorn University. After extraction, the teeth were rinsed with PBS several times. After rinsing, the periodontal ligament tissues attached to the middle third of the root were removed using a curette. The tissue explants were plated in 35-mm tissue culture dishes and grown in DMEM culture medium (Hyclone, Logan, UT, USA) with 10% FBS (Gibco BRL, Carlsbad, CA, USA), 2 mM Lglutamine (Gibco BRL), 100 U/mL penicillin (Gibco BRL), 100 µg/mL streptomycin (Gibco BRL), and 0.25 µg/mL amphotericin B (Gibco BRL) at 37ºC, 5% CO 2 , and 95% humidity. After reaching confluence, the cells were passaged with 0.25% trypsin/0.1% ethylene diaminotetraacetic acid (EDTA). Cells between the 3rd and 8th passage were used in the following studies. Three independent experiments with cells from 3 different patients were performed in each experiment, and the differences were statistically analyzed using one-way ANOVA.
Cell viability assay: A 3-(4,5-dimethylithiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to evaluate cell viability [35] . The MTT was converted by mitochondrial hydrogenases into formazen, enabling the mitochondrial activity, and cell viability to be assessed. The hPDL cells were seeded into 6-well plates and treated with various concentrations of oxyresveratrol for 24 h. MTT solution (Sigma Chemical Co, St. Louis, MO, USA) was added to each well and incubated at 37ºC for 10 min. Then, the reaction was stopped by the addition of 900 µL of dimethyl sulfoxide (DMSO) and 125 µL of glycine buffer to each well. The plate was shaken at room temperature for 10 min, and then the optical density at 570 nm was measured using an ELISA plate reader (Biotek Instruments, Winooski, VT, USA). Student's t-test was used to evaluate the differences between the cell viabilities of the untreated cells and the cells treated with different concentrations of oxyresveratrol.
Anti-inflammatory measurement: Oxyresveratrol [12] was added to hPDL cells 1 h before stimulation with 10 µg/mL LPS (from P. gingivalis). The cells were incubated for 24 h at 37ºC. The culture medium was harvested to measure the cytokine levels, and the cells were used for RNA extraction. In this experiment, 0.1% DMSO was used as an untreated control.
Reverse transcription-polymerase chain reaction (RT-PCR):
Total RNA was extracted using TRIzol reagent (Molecular Research Center, Cincinnati, OH, USA) in accordance with the manufacturer's instructions. For cDNA synthesis, 1 µg of RNA was reverse-transcribed using avian myeloblastosis virus (AMV) reverse transcriptase (Promega, Madison, WI, USA) for 1.5 h at 42ºC. Subsequently, PCR was performed using Taq polymerase (Qiagen, Hilden, Germany) with a PCR volume of 25 µL in a DNA thermal cycler (Biometra, Göttingen, Germany). The oligonucleotide sequences of the primers were as follows: IL-1, forward,  GGAGCAACAAGTGGTGTTCT,  and  reverse,  AAAGTCCAGGCTATAGCCGT;  IL-6,  forward,  CCTGAACCTTCCAAAGATGGC,  and  reverse,  CTGACCAGAAGAAGGAATGCC;  IL-8,  forward,  CGATGTCAGTGCATAAAGACA,  and  reverse,  TGAATTCTCAGCCCTCTTCAAA; and GAPDH, forward,  TGAAGGTCGGAGTCAACGGAT, and reverse, TCACACCCATGACGAACATGG. The cycling conditions for IL-6 and IL-8 were an initial 5 min denaturation step at 94ºC, followed by 30 cycles of denaturation at 94ºC for 1 min, annealing at 60ºC for 1 min, and extension at 72ºC for 2 min, followed by one extension cycle at 72ºC for 10 min. The same conditions were also used for IL-1 (37 cycles) and GAPDH (22 cycles). The PCR products were then electrophoretically separated on a 2% agarose gel and visualized by ethidium bromide fluorostaining.
Cytokine measurements: After the cells were treated with oxyresveratrol and stimulated with LPS, the cell culture medium was harvested and stored at -80ºC. The amounts of IL-1β, IL-6, and IL-8 secreted into the culture medium were determined using an enzyme-linked immunosorbent assay (ELISA) kit (R&D system, MN, USA) following the manufacturer's protocol.
Statistical analysis: Statistically significant differences between experimental means were measured using Prism software (La Jolla, CA, USA). ANOVA with a one-way classification was used in all of the experiments, and significance was recorded at the 95% confidence limit (p < 0.05).
